Chih‐Wei Yen

609 total citations
22 papers, 470 citations indexed

About

Chih‐Wei Yen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Chih‐Wei Yen has authored 22 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Chih‐Wei Yen's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Chih‐Wei Yen is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Chih‐Wei Yen collaborates with scholars based in Taiwan. Chih‐Wei Yen's co-authors include Shui‐Yi Tung, Huang‐Wei Xu, Yung‐Yu Hsieh, Hung-Yu Pan, Wan‐Ting Hsu, Chin Li, Yi‐Fang Deng, Cheng-Shyong Wu, Hsiao‐Wei D. Chiang and Sheng‐Nan Lu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Chih‐Wei Yen

22 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chih‐Wei Yen Taiwan	9	167	141	88	86	84	22	470
Bruce K. Burnett United States	13	135 0.8×	129 0.9×	121 1.4×	29 0.3×	93 1.1×	20	703
Hiroshi Ouchi Japan	15	77 0.5×	72 0.5×	106 1.2×	241 2.8×	63 0.8×	43	527
Grégorie Lebeau France	10	73 0.4×	209 1.5×	85 1.0×	131 1.5×	86 1.0×	27	460
G. Choudhuri India	16	99 0.6×	475 3.4×	150 1.7×	183 2.1×	99 1.2×	39	746
Florence Deknuydt France	9	139 0.8×	88 0.6×	179 2.0×	45 0.5×	167 2.0×	11	922
Bidhan Chandra Das Japan	14	54 0.3×	442 3.1×	174 2.0×	223 2.6×	73 0.9×	30	668
M Kubecová Czechia	7	63 0.4×	80 0.6×	86 1.0×	53 0.6×	57 0.7×	11	331
Bilkay Baştürk Türkiye	14	78 0.5×	140 1.0×	204 2.3×	27 0.3×	139 1.7×	36	651
Antonio Cuomo Italy	11	74 0.4×	196 1.4×	93 1.1×	95 1.1×	39 0.5×	15	428

Countries citing papers authored by Chih‐Wei Yen

Since Specialization

Citations

This map shows the geographic impact of Chih‐Wei Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Wei Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Wei Yen more than expected).

Fields of papers citing papers by Chih‐Wei Yen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Wei Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Wei Yen. The network helps show where Chih‐Wei Yen may publish in the future.

Co-authorship network of co-authors of Chih‐Wei Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Wei Yen. A scholar is included among the top collaborators of Chih‐Wei Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Wei Yen. Chih‐Wei Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Chung‐Kuang, Yung‐Yu Hsieh, Shui‐Yi Tung, et al.. (2022). Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting. PLoS ONE. 17(8). e0272567–e0272567. 2 indexed citations

Chang, Te‐Sheng, Shui‐Yi Tung, Kuo‐Liang Wei, et al.. (2022). Changes in renal function in patients with chronic hepatitis C treated with sofosbuvir‐velpatasvir. Advances in digestive medicine. 10(3). 150–158. 2 indexed citations

Kuo, Chia‐Jung, Puo‐Hsien Le, Wei‐Chen Tai, et al.. (2021). The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study. Journal of the Formosan Medical Association. 121(9). 1689–1695. 6 indexed citations

Chang, Te‐Sheng, Yao‐Hsu Yang, Wei‐Ming Chen, et al.. (2021). Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B. Scientific Reports. 11(1). 1365–1365. 13 indexed citations

Huang, Yu‐Ting, Yung‐Yu Hsieh, Wei‐Ming Chen, et al.. (2021). Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan. BMC Gastroenterology. 21(1). 259–259. 8 indexed citations

Lu, Chung‐Kuang, Wei‐Ming Chen, Shui‐Yi Tung, et al.. (2021). Pangenotypic direct‐acting antiviral agents for mixed genotype hepatitis C infection: A real‐world effectiveness analysis. Journal of Gastroenterology and Hepatology. 36(10). 2911–2916. 3 indexed citations

Chen, Wei‐Ming, Kuo‐Liang Wei, Shui‐Yi Tung, et al.. (2020). High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy. Journal of the Formosan Medical Association. 119(11). 1593–1600. 4 indexed citations

Tung, Shui‐Yi, Kuo‐Liang Wei, Chien‐Hung Chen, et al.. (2020). Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. PLoS ONE. 15(3). e0229994–e0229994. 13 indexed citations

Tung, Shui‐Yi, Kuo‐Liang Wei, Chien‐Heng Shen, et al.. (2019). Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin. Journal of the Formosan Medical Association. 119(1). 532–537. 3 indexed citations

10.

Yen, Chih‐Wei, Yuan‐Hung Kuo, Jing‐Houng Wang, et al.. (2018). Did AFP‐L3 save ultrasonography in community screening?. The Kaohsiung Journal of Medical Sciences. 34(10). 583–587. 5 indexed citations

11.

Huang, Mingde, et al.. (2018). Adult renal neuroblastoma. Medicine. 97(14). e0345–e0345. 5 indexed citations

12.

Hsieh, Yung‐Yu, Shui‐Yi Tung, Hung-Yu Pan, et al.. (2018). Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan. Scientific Reports. 8(1). 158–158. 213 indexed citations

13.

Hsieh, Yung‐Yu, Shui‐Yi Tung, Hung-Yu Pan, et al.. (2018). Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients. BMC Cancer. 18(1). 508–508. 28 indexed citations

14.

Yen, Chih‐Wei, et al.. (2018). Hepatocellular carcinoma with thoracic metastases presenting as hemothorax. Medicine. 97(22). e10945–e10945. 8 indexed citations

15.

Shen, Chien‐Heng, Te‐Sheng Chang, Huang‐Wei Xu, et al.. (2018). Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation. Scientific Reports. 8(1). 29 indexed citations

16.

Chiang, Hsiao‐Wei D., et al.. (2014). Experimental Investigation of the Performance of a Hermetic Screw-Expander Organic Rankine Cycle. Energies. 7(9). 6172–6185. 52 indexed citations

17.

Ling, Qing‐Dong, et al.. (2009). Prenatal Group B Streptococcus Test Using Real-Time Polymerase Chain Reaction. Taiwanese Journal of Obstetrics and Gynecology. 48(2). 116–119. 5 indexed citations

18.

Chang, Pi‐Feng, et al.. (2003). Predictive value of clinical features in differentiating group A beta-hemolytic streptococcal pharyngitis in children.. PubMed. 36(1). 21–5. 29 indexed citations

19.

Fan, Chia‐Kwung, et al.. (1999). Prevalence and treatment of Pediculus capitis infestation among aboriginal school children in northern Taiwan.. PubMed. 15(4). 209–17. 8 indexed citations

20.

Yen, J. J., et al.. (1995). Restoring the apoptosis suppression response to IL-5 confers on erythroleukemic cells a phenotype of IL-5-dependent growth.. The Journal of Immunology. 154(5). 2144–2152. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact